Precision Optics Corporation, Inc. (POCI)
USD 4.24
(3.16%)
USD 4.24
(3.16%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 2.86 Million USD | 3.31% |
| 2023 | 2.77 Million USD | -8.14% |
| 2022 | 3.02 Million USD | 60.29% |
| 2021 | 1.88 Million USD | -14.19% |
| 2020 | 2.19 Million USD | 26.67% |
| 2019 | 1.73 Million USD | 51.62% |
| 2018 | 1.14 Million USD | 8.4% |
| 2017 | 1.05 Million USD | -6.88% |
| 2016 | 1.13 Million USD | 5.61% |
| 2015 | 1.07 Million USD | 8.53% |
| 2014 | 988.87 Thousand USD | 10.34% |
| 2013 | 896.17 Thousand USD | 31.23% |
| 2012 | 682.9 Thousand USD | 2.49% |
| 2011 | 666.28 Thousand USD | -2.64% |
| 2010 | 684.32 Thousand USD | -3.5% |
| 2009 | 709.15 Thousand USD | 16.55% |
| 2008 | 608.43 Thousand USD | -32.75% |
| 2007 | 904.73 Thousand USD | 102.95% |
| 2006 | 445.8 Thousand USD | -25.65% |
| 2005 | 599.61 Thousand USD | -34.68% |
| 2004 | 917.99 Thousand USD | -26.99% |
| 2003 | 1.25 Million USD | 24.61% |
| 2002 | 1 Million USD | -33.8% |
| 2001 | 1.52 Million USD | 37.37% |
| 2000 | 1.1 Million USD | 10.95% |
| 1999 | 1 Million USD | 11.11% |
| 1998 | 900 Thousand USD | -43.75% |
| 1997 | 1.6 Million USD | -15.79% |
| 1996 | 1.9 Million USD | 26.67% |
| 1995 | 1.5 Million USD | -6.25% |
| 1994 | 1.6 Million USD | 14.29% |
| 1993 | 1.4 Million USD | 75.0% |
| 1992 | 800 Thousand USD | 0.0% |
| 1991 | 800 Thousand USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 2.97 Million USD | 7.02% |
| 2024 Q3 | 3.03 Million USD | -2.19% |
| 2024 Q2 | 3.09 Million USD | 4.33% |
| 2024 Q4 | 2.86 Million USD | -5.41% |
| 2023 Q2 | 2.84 Million USD | 3.31% |
| 2023 Q1 | 2.75 Million USD | -8.82% |
| 2023 FY | 2.77 Million USD | -8.14% |
| 2023 Q3 | 2.95 Million USD | 3.96% |
| 2023 Q4 | 2.77 Million USD | -6.2% |
| 2022 Q3 | 2.96 Million USD | 18.45% |
| 2022 FY | 3.02 Million USD | 60.29% |
| 2022 Q1 | 2.12 Million USD | 12.49% |
| 2022 Q2 | 2.5 Million USD | 18.03% |
| 2022 Q4 | 3.02 Million USD | 1.92% |
| 2021 Q3 | 1.94 Million USD | 0.22% |
| 2021 Q4 | 1.88 Million USD | -3.28% |
| 2021 FY | 1.88 Million USD | -14.19% |
| 2021 Q1 | 2.13 Million USD | -2.68% |
| 2021 Q2 | 1.94 Million USD | -9.04% |
| 2020 FY | 2.19 Million USD | 26.67% |
| 2020 Q1 | 2.07 Million USD | 19.44% |
| 2020 Q2 | 2.01 Million USD | -2.54% |
| 2020 Q3 | 2.16 Million USD | 7.35% |
| 2020 Q4 | 2.19 Million USD | 1.37% |
| 2019 FY | 1.73 Million USD | 51.62% |
| 2019 Q4 | 1.73 Million USD | 53.53% |
| 2019 Q1 | 1.11 Million USD | -2.66% |
| 2019 Q2 | 1.09 Million USD | -1.62% |
| 2019 Q3 | 1.12 Million USD | 3.13% |
| 2018 Q4 | 1.14 Million USD | 1.75% |
| 2018 FY | 1.14 Million USD | 8.4% |
| 2018 Q1 | 967.28 Thousand USD | -8.35% |
| 2018 Q2 | 987.79 Thousand USD | 2.12% |
| 2018 Q3 | 1.12 Million USD | 13.83% |
| 2017 Q3 | 1.12 Million USD | 2.31% |
| 2017 Q2 | 1.09 Million USD | 10.62% |
| 2017 FY | 1.05 Million USD | -6.88% |
| 2017 Q1 | 992.47 Thousand USD | -12.44% |
| 2017 Q4 | 1.05 Million USD | -6.03% |
| 2016 Q3 | 1.05 Million USD | -3.7% |
| 2016 Q1 | 1.01 Million USD | -5.08% |
| 2016 Q4 | 1.13 Million USD | 7.61% |
| 2016 FY | 1.13 Million USD | 5.61% |
| 2016 Q2 | 1.09 Million USD | 7.36% |
| 2015 Q1 | 911.94 Thousand USD | -7.78% |
| 2015 Q4 | 1.07 Million USD | -14.05% |
| 2015 Q3 | 1.24 Million USD | 2.21% |
| 2015 FY | 1.07 Million USD | 8.53% |
| 2015 Q2 | 1.22 Million USD | 33.97% |
| 2014 Q3 | 920.2 Thousand USD | 19.28% |
| 2014 Q4 | 988.87 Thousand USD | 7.46% |
| 2014 FY | 988.87 Thousand USD | 10.34% |
| 2014 Q2 | 771.45 Thousand USD | -4.21% |
| 2014 Q1 | 805.38 Thousand USD | -10.13% |
| 2013 Q2 | 692.13 Thousand USD | 4.93% |
| 2013 FY | 896.17 Thousand USD | 31.23% |
| 2013 Q4 | 896.17 Thousand USD | 6.27% |
| 2013 Q3 | 843.27 Thousand USD | 21.84% |
| 2013 Q1 | 659.6 Thousand USD | -3.41% |
| 2012 Q1 | 661.7 Thousand USD | -0.69% |
| 2012 Q3 | 698.35 Thousand USD | 12.2% |
| 2012 Q2 | 622.39 Thousand USD | -5.94% |
| 2012 FY | 682.9 Thousand USD | 2.49% |
| 2012 Q4 | 682.9 Thousand USD | -2.21% |
| 2011 FY | 666.28 Thousand USD | -2.64% |
| 2011 Q2 | 649.22 Thousand USD | -2.01% |
| 2011 Q1 | 662.52 Thousand USD | -3.18% |
| 2011 Q3 | 721.47 Thousand USD | 11.13% |
| 2011 Q4 | 666.28 Thousand USD | -7.65% |
| 2010 Q3 | 707.94 Thousand USD | -3.13% |
| 2010 FY | 684.32 Thousand USD | -3.5% |
| 2010 Q4 | 684.32 Thousand USD | -3.34% |
| 2010 Q2 | 730.84 Thousand USD | 4.22% |
| 2010 Q1 | 701.25 Thousand USD | -1.11% |
| 2009 Q4 | 709.15 Thousand USD | 0.43% |
| 2009 FY | 709.15 Thousand USD | 16.55% |
| 2009 Q2 | 626.66 Thousand USD | 0.33% |
| 2009 Q3 | 706.12 Thousand USD | 12.68% |
| 2009 Q1 | 624.58 Thousand USD | 2.66% |
| 2008 Q2 | 679.88 Thousand USD | -2.82% |
| 2008 Q3 | 623.09 Thousand USD | -8.35% |
| 2008 Q4 | 608.43 Thousand USD | -2.35% |
| 2008 Q1 | 699.59 Thousand USD | -22.67% |
| 2008 FY | 608.43 Thousand USD | -32.75% |
| 2007 Q3 | 996.99 Thousand USD | 94.89% |
| 2007 Q4 | 904.73 Thousand USD | -9.25% |
| 2007 FY | 904.73 Thousand USD | 102.95% |
| 2007 Q1 | 500.33 Thousand USD | 12.23% |
| 2007 Q2 | 511.55 Thousand USD | 2.24% |
| 2006 Q4 | 445.8 Thousand USD | -19.25% |
| 2006 Q2 | 530.85 Thousand USD | -11.21% |
| 2006 Q1 | 597.84 Thousand USD | -0.3% |
| 2006 FY | 445.8 Thousand USD | -25.65% |
| 2006 Q3 | 552.09 Thousand USD | 4.0% |
| 2005 FY | 599.61 Thousand USD | -34.68% |
| 2005 Q1 | 816.46 Thousand USD | -11.06% |
| 2005 Q3 | 798.22 Thousand USD | 8.91% |
| 2005 Q4 | 599.61 Thousand USD | -24.88% |
| 2005 Q2 | 732.92 Thousand USD | -10.23% |
| 2004 Q1 | 1.25 Million USD | 0.06% |
| 2004 FY | 917.99 Thousand USD | -26.99% |
| 2004 Q4 | 917.99 Thousand USD | -20.6% |
| 2004 Q3 | 1.15 Million USD | -7.81% |
| 2004 Q2 | 1.25 Million USD | -0.31% |
| 2003 FY | 1.25 Million USD | 24.61% |
| 2003 Q4 | 1.25 Million USD | 1.24% |
| 2003 Q3 | 1.24 Million USD | 6.56% |
| 2003 Q2 | 1.16 Million USD | 7.75% |
| 2003 Q1 | 1.08 Million USD | 7.19% |
| 2002 FY | 1 Million USD | -33.8% |
| 2002 Q4 | 1 Million USD | -9.51% |
| 2002 Q3 | 1.11 Million USD | 0.89% |
| 2002 Q2 | 1.1 Million USD | -3.75% |
| 2002 Q1 | 1.14 Million USD | -24.66% |
| 2001 Q2 | 1.29 Million USD | 5.19% |
| 2001 Q4 | 1.52 Million USD | 15.97% |
| 2001 FY | 1.52 Million USD | 37.37% |
| 2001 Q1 | 1.22 Million USD | 10.63% |
| 2001 Q3 | 1.31 Million USD | 1.8% |
| 2000 Q2 | 1 Million USD | 11.11% |
| 2000 FY | 1.1 Million USD | 10.95% |
| 2000 Q3 | 925.88 Thousand USD | -7.41% |
| 2000 Q1 | 900 Thousand USD | -10.0% |
| 2000 Q4 | 1.1 Million USD | 19.83% |
| 1999 Q4 | 1 Million USD | 0.0% |
| 1999 FY | 1 Million USD | 11.11% |
| 1999 Q1 | 1.1 Million USD | 22.22% |
| 1999 Q2 | 1 Million USD | -9.09% |
| 1999 Q3 | 1 Million USD | 0.0% |
| 1998 Q1 | 1.5 Million USD | -6.25% |
| 1998 Q4 | 900 Thousand USD | -25.0% |
| 1998 Q3 | 1.2 Million USD | -7.69% |
| 1998 Q2 | 1.3 Million USD | -13.33% |
| 1998 FY | 900 Thousand USD | -43.75% |
| 1997 Q2 | 1.9 Million USD | 5.56% |
| 1997 Q4 | 1.6 Million USD | -15.79% |
| 1997 FY | 1.6 Million USD | -15.79% |
| 1997 Q1 | 1.8 Million USD | -5.26% |
| 1997 Q3 | 1.9 Million USD | 0.0% |
| 1996 FY | 1.9 Million USD | 26.67% |
| 1996 Q3 | 1.9 Million USD | 11.76% |
| 1996 Q1 | 1.4 Million USD | -6.67% |
| 1996 Q2 | 1.7 Million USD | 21.43% |
| 1996 Q4 | 1.9 Million USD | 0.0% |
| 1995 Q3 | 1.4 Million USD | 7.69% |
| 1995 Q4 | 1.5 Million USD | 7.14% |
| 1995 Q2 | 1.3 Million USD | -13.33% |
| 1995 Q1 | 1.5 Million USD | -6.25% |
| 1995 FY | 1.5 Million USD | -6.25% |
| 1994 Q2 | 1.9 Million USD | 18.75% |
| 1994 Q3 | 1.8 Million USD | -5.26% |
| 1994 Q4 | 1.6 Million USD | -11.11% |
| 1994 FY | 1.6 Million USD | 14.29% |
| 1994 Q1 | 1.6 Million USD | 14.29% |
| 1993 Q3 | 1.4 Million USD | -6.67% |
| 1993 Q2 | 1.5 Million USD | 50.0% |
| 1993 Q1 | 1 Million USD | 25.0% |
| 1993 FY | 1.4 Million USD | 75.0% |
| 1993 Q4 | 1.4 Million USD | 0.0% |
| 1992 FY | 800 Thousand USD | 0.0% |
| 1992 Q4 | 800 Thousand USD | 0.0% |
| 1991 FY | 800 Thousand USD | 0.0% |
| 1991 Q4 | 800 Thousand USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 17.87 Million USD | 83.956% |
| AngioDynamics, Inc. | 60.61 Million USD | 95.268% |
| AtriCure, Inc. | 67.89 Million USD | 95.776% |
| Avinger, Inc. | 5.29 Million USD | 45.864% |
| Azenta, Inc. | 128.19 Million USD | 97.763% |
| BioLife Solutions, Inc. | 43.45 Million USD | 93.4% |
| The Cooper Companies, Inc. | 735.6 Million USD | 99.61% |
| Daxor Corporation | - USD | -Infinity% |
| Ekso Bionics Holdings, Inc. | 5.05 Million USD | 43.206% |
| Femasys Inc. | 667.11 Thousand USD | -329.924% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 24.71 Million USD | 88.396% |
| Hologic, Inc. | 679.8 Million USD | 99.578% |
| ICU Medical, Inc. | 709.36 Million USD | 99.596% |
| Intuitive Surgical, Inc. | 1.22 Billion USD | 99.765% |
| KORU Medical Systems, Inc. | 3.48 Million USD | 17.614% |
| LeMaitre Vascular, Inc. | 52.33 Million USD | 94.52% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -234.762% |
| Innovative Eyewear, Inc. | 856.75 Thousand USD | -234.762% |
| Masimo Corporation | 545 Million USD | 99.474% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 1.61 Million USD | -77.347% |
| Merit Medical Systems, Inc. | 303.87 Million USD | 99.056% |
| Nephros, Inc. | 2.47 Million USD | -16.117% |
| NovoCure Limited | 38.15 Million USD | 92.482% |
| NEXGEL, Inc. | 1.31 Million USD | -117.445% |
| NEXGEL, Inc. | 1.31 Million USD | -117.445% |
| Singular Genomics Systems, Inc. | 13.57 Million USD | 78.868% |
| OraSure Technologies, Inc. | 47.61 Million USD | 93.976% |
| Pro-Dex, Inc. | 15.26 Million USD | 81.216% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 494.37 Thousand USD | -480.148% |
| QuidelOrtho Corporation | 577.8 Million USD | 99.504% |
| Repligen Corporation | 202.32 Million USD | 98.582% |
| Sanara MedTech Inc. | 4.71 Million USD | 39.203% |
| STAAR Surgical Company | 35.13 Million USD | 91.836% |
| Sharps Technology, Inc. | 1.7 Million USD | -67.81% |
| Utah Medical Products, Inc. | 9.58 Million USD | 70.068% |
| DENTSPLY SIRONA Inc. | 624 Million USD | 99.54% |
| Jin Medical International Ltd. | 5.05 Million USD | 43.241% |